Next Article in Journal
Cryopreservation of Whole Tumor Biopsies from Rectal Cancer Patients Enable Phenotypic and In Vitro Functional Evaluation of Tumor-Infiltrating T Cells
Next Article in Special Issue
Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
Previous Article in Journal
Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer
 
 
Review
Peer-Review Record

Does the Microenvironment Hold the Hidden Key for Functional Precision Medicine in Pancreatic Cancer?

Cancers 2021, 13(10), 2427; https://doi.org/10.3390/cancers13102427
by John Kokkinos 1,2,†, Anya Jensen 3,4,†, George Sharbeen 1, Joshua A. McCarroll 2,3,4, David Goldstein 1,5, Koroush S. Haghighi 5 and Phoebe A. Phillips 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Cancers 2021, 13(10), 2427; https://doi.org/10.3390/cancers13102427
Submission received: 27 April 2021 / Revised: 11 May 2021 / Accepted: 12 May 2021 / Published: 17 May 2021

Round 1

Reviewer 1 Report

This is a well written review on the subject of pancreatic cancer modeling platforms being utilized to guide selection of therapy. The focus is on the role of the tumor microenvironment (TME) and its contribution to drug resistance. The review is comprehensive, cites important recent literature and fairly describes the strengths and weaknesses of various models. The authors touch briefly on the question of metastatic disease and the question of how the TME may differ from that of the primary. Given most patients present with metastatic disease, it would be helpful to clarify the tissue requirements for tumor explant/slice culture and the limitations in testing multiple therapies  using this method. I would also be interested in the authors perspective on how best to validate these preclinical models as truly clinical useful- ie) what types of co-clinical trial design might they feel would be informative to provide sufficient evidence for adoption. Finally, a comment on the actual efficacy endpoints used in these models would helpful- should we be measuring proliferation, cell death, changes in metabolism- a combination? Overall, a well written paper summarizing the state of the field.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The article from Kokkinos and colleagues discusses the role of the tumor microenvironment on chemotherapy and the need to integrate the tumor microenvironment into precision medicine pipelines for pancreatic cancer. The article is very informative, well written and includes the most recent and relevant literature. The structure of the article is excellent and guides the reader through an interesting and important topic. I only have two minor comments: (1) there is a spelling mistake on page 2, line 63 for 5-Fluorouracil. (2) Page 7, line 224, I thought the first study using sonic hedgehog pathway inhibitors was published from Kenneth Olive and colleagues in 2009 in Science.

I congratulate the authors for this wonderful review.

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop